Grants and Contributions:
Title:
Biosynthesis of Rare Cannabinoids using a Yeast-Based Biosynthesis platform
Agreement Number:
954743
Agreement Value:
$140,000.00
Agreement Date:
Jul 15, 2020 - Mar 31, 2021
Description:
This project will establish a yeast based biosynthesis platform for rare cannabinoids with high potential of therapeutic benefits.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5M 2Z3
Reference Number:
172-2020-2021-Q2-954743
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830261103
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 75 days. The total amended value is 85,000 dollars.
Amendment Date
Mar 12, 2021
Recipient's Operating Name:
formerly BioCan Technologies Inc.
Recipient's Legal Name:
Willow Analytics Inc.
Federal Riding Name:
Vancouver Kingsway
Federal Riding Number:
59038
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: